REQUEST A DEMO
Total
USD $0.00
Search more companies

Lotus Pharmaceutical Co., Ltd. (Taiwan, China)

Main Activities: Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing
Full name: Lotus Pharmaceutical Co., Ltd. Profile Updated: March 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Mesyrel Chemical & Pharmaceutical Ltd. was established in 1966.In 1968 it was re-organized as Mesyrel Chemical Pharmaceutical Co., Ltd.. In 1990 Mesyrel's (Trazodone)Bio-equivalent studies were approved by the Health Department. In 1991 Mesyrel was licensed and included in the new monitoring drugs.In 1992 Befon (Baclofen) cattle-equivalent studies were approved. In 1993 Mesyrel exported to the mainland. In 1996 Forflow SR long-acting formulations of the pipeline was listed. In 1998 the monitoring drugs Bensau and Ichderm were listed. Bensau and Fisherman's pharmaceutical were in cooperation. In 1999 MuactionSR long-acting formulations of the pipeline was listed. The monitoring drugs such as Nimed,Apano, Musgud and Detosiv were listed in 2000,2001 and 2002.In 2003 it established the International Department. Acne patented E-do was first listed in Taiwan.

Headquarters
17F., No.277, Songren Rd., Xin Yi Dist
Taipei City; Taipei City;

Contact Details: Purchase the Lotus Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.lotuspharm.com.tw

Basic Information
Total Employees:
Purchase the Lotus Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Lotus Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Lotus Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
June 30, 1966
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51.02%
Purchase this report to view the information.
6.67%
Purchase this report to view the information.
0.67%
Purchase this report to view the information.
0.66%
Purchase this report to view the information.
0.54%
Subsidiaries
Alvogen Korea Holdings Ltd. (South Korea)
100%
Alvogen Pharma India Pvt Ltd (Indonesia)
100%
Lotus International Pte Ltd
100%
Company Performance
Financial values in the chart are available after Lotus Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
18.13%
Total operating revenue
18.37%
Operating profit (EBIT)
25.32%
EBITDA
23.18%
Net Profit (Loss) for the Period
29.88%
Total assets
22.59%
Total equity
24.87%
Operating Profit Margin (ROS)
2%
Net Profit Margin
2.48%
Return on Equity (ROE)
0.85%
Debt to Equity Ratio
12.47%
Quick Ratio
-0%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?